Novel System Aids Surgical Removal of Tissue

A novel system provides surgeons with the ability to separate the steps needed to access diseased or unwanted tissue, such as liver lesions, from the actual step of ablating that tissue.

Called the CoAccess System, the system consists of an Introducer set and a LeVeen CoAccess Electrode. The introducer set, composed of an insulated cannula and stylet, is used to target liver lesions or other soft tissue. Once the set is in place, the clinician may use the cannula for a multipurpose access channel to the site. The cannula mates with a LeVeen CoAccess Electrode for radiofrequency ablation of the lesion.

The system was developed by RadioTherapeutics Corp. (Sunnyvale, CA, USA) and has been cleared by the U.S. Food and Drug Administration (FDA) for the general ablation of diseased soft tissue and for the specific ablation of nonresectable lesions of the liver. RadioTherapeutics is focused on the development of cost-effective, minimally invasive products that help surgeons, radiologists, and other interventional doctors manage cancers not amenable to resection or chemotherapy.



Related Links:
RadioTherapeutics